相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Markers of systemic inflammation in children with hyperuricemia
Anna Wasilewska et al.
ACTA PAEDIATRICA (2012)
Worldwide implementation of the WHO Child Growth Standards
Mercedes de Onis et al.
PUBLIC HEALTH NUTRITION (2012)
Relationships Among Hyperuricemia, Metabolic Syndrome, and Endothelial Function
Hirofumi Tomiyama et al.
AMERICAN JOURNAL OF HYPERTENSION (2011)
Time course of asymmetric dimethylarginine (ADMA) and oxidative stress in fructose-hypertensive rats: A model related to metabolic syndrome
C. Korandji et al.
ATHEROSCLEROSIS (2011)
Symmetrical and Asymmetrical Dimethylarginine as Predictors for Mortality in Patients Referred for Coronary Angiography: The Ludwigshafen Risk and Cardiovascular Health Study
Andreas Meinitzer et al.
CLINICAL CHEMISTRY (2011)
Asymmetric dimethylarginine as a risk factor for cardiovascular disease in Japanese patients with type 2 diabetes mellitus
Ippei Kanazawa et al.
CLINICAL ENDOCRINOLOGY (2011)
Symmetric Dimethylarginine as a Proinflammatory Agent in Chronic Kidney Disease
Eva Schepers et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke
Friedrich Schulze et al.
ATHEROSCLEROSIS (2010)
The height-, weight-, and BMI-for-age of Polish school-aged children and adolescents relative to international and local growth references
Zbigniew Kulaga et al.
BMC PUBLIC HEALTH (2010)
Association between endothelial dysfunction and hyperuricaemia
Wan-Jing Ho et al.
RHEUMATOLOGY (2010)
Endothelial Function and Oxidative Stress in Cardiovascular Diseases
Yukihito Higashi et al.
CIRCULATION JOURNAL (2009)
Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells
Sergey Zharikov et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2008)
Effects of acute and chronic L-arginine treatment in experimental hyperuricemia
Laura G. Sanchez-Lozada et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Uric acid and endothelial dysfunction in essential hypertension
Carmine Zoccali et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Uric acid-induced C-reactive protein expression: Implication on cell proliferation and nitric oxide production of human vascular cells
DH Kang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Hyperuricemia induces endothelial dysfunction
UM Khosla et al.
KIDNEY INTERNATIONAL (2005)
Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality
RH Boger et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2005)
Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese women
K Krzyzanowska et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Endothelial function, inflammation, and prognosis in cardiovascular disease
MA Gonzalez et al.
AMERICAN JOURNAL OF MEDICINE (2003)
Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases
C Fleck et al.
CLINICA CHIMICA ACTA (2003)
Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?
RJ Johnson et al.
HYPERTENSION (2003)
Endothelial dysfunction - A marker of atherosclerotic risk
PO Bonetti et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Impaired nitric oxide synthase pathway in diabetes mellitus - Role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase
KY Lin et al.
CIRCULATION (2002)
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease:: a prospective study
C Zoccali et al.
LANCET (2001)
分享论文
